Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bipolar Disorder

• Lithium Versus Lamotrigine in Bipolar Disorder, Type II
• The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
• Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
• Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
• PEA vs. Placebo for Major Depression
• Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
• Synaptic Imaging and Network Activity in Treatment Resistant Depression
• Cannabidiol for Bipolar Depression (CBD-BD)
• Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
• Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
• The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
• A Randomised Controlled Feasibility Trial of Culturally Adapted Psychoeducation (CaPE) for Bipolar Disorders in Nigeria
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
• Clinical Predictors of Intravenous Ketamine Response in Treatment-Resistant Depression
• Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
• Multi-factor Model Constraction for Early Warning and Diagnosis of MDD
• Vortioxetine Adjunctive Treatment in Bipolar Depression
• Chinese Longitudinal and Systematic Study of Bioplar Disorder
• Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
• Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
• Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
• A Study of JNJ-55308942 in the Treatment of Bipolar Depression
• OSU6162 in Bipolar Depression (OBID)
• Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression
• Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
• Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
• Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
• Dopamine D3 Receptor Occupancy in Bipolar Depression
• AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
• Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)
• Mind to Quit Multisite Trial
• Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
• Ketamine for Treatment-Resistant Bipolar Disorder
• Ketamine as an Adjunctive Therapy for Major Depression (2)
• Clonidine to Prevent Delirium After Electroconvulsive Therapy.
• A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid
• IM Ketamine vs Midazolam for Suicidal ER Patients
• Brexpiprazole Treatment for Bipolar I Depression
• Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder
• The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
• Candesartan as an Adjunctive Treatment for Bipolar Depression
• Treatment of Bipolar Depression With Pentoxifylline
• The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
• Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
• 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
• Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers
• Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder
• Scopolamine in Bipolar Depression
• A Study of Staccato Loxapine (ADASUVE®) for Inhalation
• Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder
• Pramipexole to Target "Anhedonic Depression"
• Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
• Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
• Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• Brain Insulin Resistance in Mood Disorders
• 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
• Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
• Treating Smokers With Mental Illness
• This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications.
• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
• Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
• Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
• Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
• A Study to Evaluate SAGE-217 in Subjects With Bipolar I/II Disorder With a Current Major Depressive Episode - Part A
• Ketamine Versus Electroconvulsive Therapy in Depression
• Imaging 5HT7 Antagonist Effects in Bipolar Disorder
• Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
• Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
• Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression
• Brexpiprazole for Bipolar Depression
• A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
• CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
• NRX101 Glx Biomarker Validation Study
• NRX101 Glx Biomarker Validation Study
• NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
• NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
• NRX101 for Moderate Bipolar Depression and Suicidal Ideation
• A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder
• Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
• Effects of Erythropoietin for Cognitive Side-effects of ECT
• Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders
• Cannabidiol as an Adjunctive Treatment for Bipolar Depression
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
• Ketamine as an Adjunctive Therapy for Major Depression
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
• Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics
• SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)
• Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
• Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder
• Ebselen as an add-on Treatment in Hypo/Mania
• Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
• Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum
• Sequential Therapy for the Treatment of Severe Bipolar Depression.
• Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
• Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
• Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
• Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
• Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
• Gao NARASD Lithium Study
• Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
• The UTHealth Ketamine Project
• Cost- Effectiveness and Quality of Life Assessment in Mood Disorder
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
• Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
• Trehalose as add-on Therapy in Bipolar Depression
• Depression, Obesity and Inflammatory Markers
• Nitrous TRD Bipolar Depression
• Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients
• Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression
• A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
• Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
• Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
• Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
• Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
• Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
• DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression
• Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
• Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
• Antipsychotics and Risk of Hyperglycemic Emergencies
• Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
• Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth
• Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
• Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder
• Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
• Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
• Role Functioning Changes NOS
• Lithium Therapy: Understanding Mothers, Metabolism and Mood
• BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
• Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
• Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
• Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients
• Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
• Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
• Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder
• Iloperidone in Mixed States of Bipolar Disorder
• Targeting Cognition in Bipolar Disorder With Pramipexole
• 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
• 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
• Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
• Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
• Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder
• Characterization of the Prosocial and Prosexual Effects of GHB
• Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
• Microbiome of Depression & Treatment Response to Citalopram
• Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
• NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression
• Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)
• Biosignatures of Latuda for Bipolar Depression
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
• Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
• Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
• Ondansetron for Bipolar Disorder and Alcohol Use Disorders
• Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
• Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
• The Effect of Methylphenidate on Cognitive Abilities of Adults With Bipolar Disorder
• Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder
• Pregnant Women Taking Lamictal for Bipolar Disorder
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.
• Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
• Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
• Bio-equivalence Study Between SAPHRIS and Asenapine
• Ketamine for Suicidality in Bipolar Depression
• Algorithm Guided Treatment Strategies for Bipolar Depression
• Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
• Lithium for Suicidal Behavior in Mood Disorders
• Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations
• Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium
• Pediatric Open-Label Extension Study
• Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
• Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder
• Vitamin D Supplementation for Bipolar Depression
• Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
• PET and MRI Brain Imaging of Bipolar Disorder
• Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
• Naltrexone for Antipsychotic-Induced Weight Gain
• Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder
• NMDA Antagonists in Bipolar Depression
• Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
• Asenapine for Bipolar Depression
• Uridine Adolescent Bipolar Depression Randomized Controlled Trial
• N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
• Omega-3 Dietary Supplements in Schizophrenia
• Adjunctive Isradipine for the Treatment of Bipolar Depression
• Trial of Ketamine and Lithium Therapy in Bipolar Depression
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
• Long-term Study of FK949E in Elderly Bipolar Disorder Patients
• A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
• Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
• Pioglitazone for the Treatment of Bipolar Depression
• A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder
• Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
• Simvastatin Augmentation of Lithium Treatment in Bipolar Depression
• Prazosin as an Antimanic Agent in Severe Mania or Mixed States
• Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
• Lamotrigine Phase III Study in Bipolar I Disorder
• Sequential Multiple Assignment Treatment for Bipolar Disorder
• Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
• Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression
• Zonisamide for Heavy Drinkers With Bipolar Disorder
• Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology
• Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder
• Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
• Methylphenidate for the Treatment of Acute Mania
• Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
• Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II
• Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital
• Gao Bipolar Spectrum Lithium/Quetiapine Study
• Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
• Minocycline for Bipolar Depression
• Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified
• Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
• Risk Factors for AD-Associated Switch to Mania
• An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
• Lurasidone Extended Use Study
• Bipolar Depression and Inflammation
• Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder
• Decision-Making in Bipolar Disorder
• Asenapine in the Treatment of Older Adults With Bipolar Disorder
• Wake Therapy in the Treatment of Depression
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
• Tranylcypromine Treatment of Bipolar Depression
• Minocycline and Aspirin in the Treatment of Bipolar Depression
• Special Drug Use Investigation for LAMICTAL Bipolar
• Sustaining Remission of Psychotic Depression
• Lithium Versus Paroxetine in Major Depression
• Study Using Pregnenolone to Treat Bipolar Depression
• Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
• Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
• Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
• A Study of LY2979165 in Healthy Subjects
• Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)
• Comparative Effectiveness Study for Bipolar Disorder
• Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
• Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression
• Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
• Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
• To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
• Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
• A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
• A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers
• Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)
• Neurophysiologic Changes in Patients With Bipolar Depression
• Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
• Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder
• Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451
• Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
• The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
• Add-on Dextromethorphan in Bipolar Disorders
• Series Studies of Bipolar Disorder-Valproate add-on Memantine
• Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
• Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
• Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.
• Acute Psychotherapy for Bipolar II Depression
• Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
• Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
• Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
• Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
• One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
• A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
• Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
• Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder
• Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
• Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder
• Lamotrigine Pregnancy Registry (LAM05)
• Safety and Efficacy of Cariprazine for Bipolar I Disorder
• Safety and Efficacy of Cariprazine for Mania
• A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
• Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
• A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
• Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania
• Bipolar Depression Before and After Lamotrigine Treatment
• Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
• Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
• Juvenile Bipolar Disorder Outpatient Program
• Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release
• A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders
• A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients
• Prevention of Relapse & Recurrence of Bipolar Depression
• Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
• Treatment Study of Bipolar Depression
• A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)
• A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers
• Adult Bipolar Mania
• Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
• Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
• Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
• To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions
• To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
• Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.
• A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects
• Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
• Multimodal Neuroimaging of Treatment Effects in Adolescent Mania
• A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder
• Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
• Efficacy of Adjunctive Tianeptine in the Treatment of Bipolar Depression
• Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
• Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients
• Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
• Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy
• Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
• Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression
• Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
• A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
• Oral Uridine for Treatment of Bipolar Depression in Adolescents
• A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
• Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
• An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
• Varenicline in Bipolar Depressed Patients
• Pediatric Bipolar Depression
• Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
• Liothyronine (T3) for Bipolar Depression
• Determination of Absorption and Elimination of Lamotrigine-XR
• Bipolar Disorder in Late Life
• Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression
• A Study in the Treatment of Acute Mania
• A Trial of SAMe for Treatment-Resistant Bipolar Depression
• Sensoril(Ashwaganhda)for Bipolar Disorder
• Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
• Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
• Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
• To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.
• Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder
• Allopurinol Maintenance Study for Bipolar Disorder
• Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
• Lamotrigine Therapy in Geriatric Bipolar Depression
• CoQ10 in Geriatric Bipolar Depression
• The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder
• Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder
• Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
• Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
• Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
• Memantine and Cognitive Dysfunction in Bipolar Disorder
• Allopurinol Add-on Treatment for Refractory Mania
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
• Ziprasidone in Pediatric Bipolar Disorder
• Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
• Lamotrigine for Symptoms of Geriatric Bipolar Depression
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
• Citicoline for Bipolar 1 Disorder and Cocaine Dependence
• Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder
• Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
• Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
• A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
• Antidepressant Therapy in Treating Bipolar Type II Major Depression
• Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions
• Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions
• Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions
• Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions
• Cognitive Enhancement in Bipolar Disorder
• FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
• A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
• Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
• Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
• Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
• Memantine and Cognitive Dysfunction in Bipolar Disorder
• Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
• The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
• Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females
• Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
• Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
• Levetiracetam in the Management of Bipolar Depression
• Ceftriaxone in the Management of Bipolar Depression
• A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -
• Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
• Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
• Efficacy of Allopurinol and Dypiridamole in Acute Mania
• Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
• Antibodies to Digoxin for Bipolar Disorder
• An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients
• Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults
• Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
• Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
• Riluzole in the Treatment of Bipolar Depression
• Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
• A Pilot Study Assessing EmSam in Bipolar Depression
• Early Detection and Intervention for the Prevention of Psychosis
• Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
• An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
• Pharmacotherapy of Treatment-Resistant Mania
• A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
• Olanzapine Treatment of Patients With Bipolar I Disorder
• Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers
• A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
• Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania
• GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
• FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
• Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
• Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
• ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
• Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
• Oral Contraceptive Interaction Study for GW273225
• Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
• Geodon in Weight Loss Study for Bipolar Disorders
• Acamprosate vs. Placebo in Bipolar Alcoholics
• Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment
• Lamictal Bipolar Observational Study
• Prevention of Mood Disorders by Folic Acid Supplementation
• Quetiapine for Bipolar Disorder and Alcohol Dependence
• Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
• Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
• Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
• Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
• Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients
• Valproic Acid Sodium Salt in Bipolar Disorder
• Effects of Pentazocine Versus Lorazepam on Manic Symptoms
• Research Study of Bipolar Mood Symptoms and Cognitive Problems
• Safety and Efficacy Study of Lithium in Bipolar Disorder
• Phase III/Seroquel SR Bipolar Depression Monotherapy - US
• Phase 3 /Seroquel SR Acute Mania Monotherapy - US
• Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
• Tamoxifen in Treatment of Acute Mania
• Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
• Cannabinoids in Bipolar Affective Disorder
• Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes
• Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
• Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
• An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
• A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
• Taurine in Adolescents With Bipolar Disorder
• Medication, Weight Gain and GI Hormones
• A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
• A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression
• Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
• A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
• The Antidepressant Efficacy of the Anticholinergic Scopolamine
• A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
• An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
• RU-486 in the Treatment of Bipolar Depression
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
• A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
• A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
• Open Label Trial of Acamprosate in Bipolar Alcoholics
• Ziprasidone And Olanzapine's Outcomes In Mania
• Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
• Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
• Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
• Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
• Ropinirole in the Treatment of Bipolar Depression
• The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder
• Quetiapine Fumarate Bipolar Maintenance Monotherapy
• 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
• Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
• Optimizing Pharmacotherapy for Bipolar Alcoholics
• A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
• Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
• Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
• Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
• A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
• Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
• Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms
• Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
• Bipolar II Depression: Lithium, SSRI, or the Combination
• Depression And Bipolar Disorder
• Treatment Resistant Bipolar Depression
• Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
• VALID : VAlproate Versus LIthium in Bipolar Disorders
• ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
• A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
• Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
• Study of Aripiprazole in Patients With Bipolar I Disorder
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
• Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling
• Treatment of Bipolar Mania in Older Adults
• A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
• A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
• Genetic Predictors of Lithium Response in Bipolar Disorder
• Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
• Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
• A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
• Insulin Resistance in Patients With Mood Disorder
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
• Valproate Efficacy in Cocaine-Bipolar Comorbidity
• Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting
• A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
• Depakote-ER for Depressive and Bipolar Depression
• Aripiprazole in the Treatment of Bipolar Depression
• Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder
• The Effects of Aripiprazole on Patients With Metabolic Syndrome
• A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
• Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
• 12- Week Open Label Treatment of Refractory Bipolar Depression
• Naltrexone for Bipolar Disorder and Alcohol Dependence
• Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
• Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence
• Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study
• An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
• Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse
• Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
• An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
• Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
• An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
• Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
• Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study
• Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
• The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania
• Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
• Bipolar Disorder Research Study for Ages 12 and Older
• Depakote ER Therapy for Mania Comorbid With Substance Abuse
• Abilify Therapy for Reducing Comorbid Substance Abuse
• Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania
• Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?
• Seroquel in Bipolar Depression Versus Lithium
• Metabolic Effects of Antipsychotics in Children
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
• Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
• Indicated Prevention of Psychotic Disorders With Low-dose Lithium
• Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
• Aripiprazole Treatment of Bipolar Depression
• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
• Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
• Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
• Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
• Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
• Aripiprazole in Late Life Bipolar Disorder
• Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
• Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
• Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
• Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
• Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression
• Depakote ER in Bipolar Depression
• Short Term Rescue Study of Olanzapine
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
• Maintenance Treatment of Bipolar Depression
• Treatment of Mania Symptoms With Drug Therapy
• Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
• Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
• Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
• Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
• Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
• Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
• Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
• Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
• Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
• Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
• Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
• Risperdal Consta for Bipolar Disorder
• Lamotrigine Monotherapy in Pediatric Bipolar Disorder
• Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
• A Study of Risperidone Monotherapy in Bipolar Anxiety
• Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
• 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)
• 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)
• 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
• Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
• Escitalopram as a Mood Stabilizer for Bipolar II Disorder
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.
• Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
• Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder
• 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)
• 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)
• 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)
• A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
• Valnoctamide in Mania
• Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder
• Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
• Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
• Study Evaluating Bifeprunox in Bipolar Depression
• A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes
• Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
• SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
• Effects of Pentazocine on Manic Symptoms
• Seroquel in Bipolar Depression Versus SSRI
• Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
• Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder
• Aripiprazole in Children and Adolescents With Bipolar I Disorder
• Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
• Aripiprazole Open-Label, Safety and Tolerability Study
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
• Study of Aripiprazole in Patients With Acute Bipolar Mania
• Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
• Aripiprazole in Patients With Acute Mania
• A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
• Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
• Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
• Rapid Antidepressant Effects of Ketamine in Major Depression
• Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
• Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
• Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
• Acute Treatment of Bipolar II Depression
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
• Bipolar Study in Adults at Least 18 Years of Age
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
• Combination Therapy for the Treatment of Bipolar Disorders
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
• Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
• Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
• Bipolar Disorder Study for Men and Women
• Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
• Riluzole to Treat Depression in Bipolar Disorder
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
• Treatment and Outcome of Early Onset Bipolar Disorder
• Open-label Adjunctive Zonisamide for Bipolar Disorder
• Optimizing Electroconvulsive Therapy for Depression
• Relapse Prevention for Bipolar Type-II Disorder
• The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
• Clinical Trial of Mifepristone for Bipolar Depression
• A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
• Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
• Study of Aripiprazole in Patients With a History of Bipolar Disorder
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
• A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
• A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
• Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
• Clozapine for Treatment-Resistant Mania
• Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder
• Clinical Trial of Pramipexole in Bipolar Depression
• Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
• Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
• Omega-3 Fatty Acids in Bipolar Disorder
• Treatment of Depression in Youth With Bipolar Disorders
• Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
• Drug Treatment for Alcoholics With Bipolar Disorder
• Maintenance Therapies in Bipolar Disorders